326 related articles for article (PubMed ID: 9175839)
21. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
[TBL] [Abstract][Full Text] [Related]
22. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues.
Galocha B; Hill A; Barnett BC; Dolan A; Raimondi A; Cook RF; Brunner J; McGeoch DJ; Ploegh HL
J Exp Med; 1997 May; 185(9):1565-72. PubMed ID: 9151894
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly.
Hengel H; Flohr T; Hämmerling GJ; Koszinowski UH; Momburg F
J Gen Virol; 1996 Sep; 77 ( Pt 9)():2287-96. PubMed ID: 8811029
[TBL] [Abstract][Full Text] [Related]
24. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
[TBL] [Abstract][Full Text] [Related]
25. MHC class I-subversive gene functions of cytomegalovirus and their regulation by interferons-an intricate balance.
Benz C; Hengel H
Virus Genes; 2000; 21(1-2):39-47. PubMed ID: 11022788
[TBL] [Abstract][Full Text] [Related]
26. Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.
Koppers-Lalic D; Reits EA; Ressing ME; Lipinska AD; Abele R; Koch J; Marcondes Rezende M; Admiraal P; van Leeuwen D; Bienkowska-Szewczyk K; Mettenleiter TC; Rijsewijk FA; Tampé R; Neefjes J; Wiertz EJ
Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5144-9. PubMed ID: 15793001
[TBL] [Abstract][Full Text] [Related]
27. Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2.
Gewurz BE; Gaudet R; Tortorella D; Wang EW; Ploegh HL; Wiley DC
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6794-9. PubMed ID: 11391001
[TBL] [Abstract][Full Text] [Related]
28. A viral inhibitor of peptide transporters for antigen presentation.
Früh K; Ahn K; Djaballah H; Sempé P; van Endert PM; Tampé R; Peterson PA; Yang Y
Nature; 1995 Jun; 375(6530):415-8. PubMed ID: 7760936
[TBL] [Abstract][Full Text] [Related]
29. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
[TBL] [Abstract][Full Text] [Related]
30. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.
Lehner PJ; Karttunen JT; Wilkinson GW; Cresswell P
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6904-9. PubMed ID: 9192664
[TBL] [Abstract][Full Text] [Related]
31. Peptide size selection by the major histocompatibility complex-encoded peptide transporter.
Momburg F; Roelse J; Hämmerling GJ; Neefjes JJ
J Exp Med; 1994 May; 179(5):1613-23. PubMed ID: 8163941
[TBL] [Abstract][Full Text] [Related]
32. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
Oresic K; Ng CL; Tortorella D
J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
[TBL] [Abstract][Full Text] [Related]
33. Peptide selection by MHC-encoded TAP transporters.
Momburg F; Neefjes JJ; Hämmerling GJ
Curr Opin Immunol; 1994 Feb; 6(1):32-7. PubMed ID: 8172678
[TBL] [Abstract][Full Text] [Related]
34. The influence of TAP1 and TAP2 gene polymorphisms on TAP function and its inhibition by viral immune evasion proteins.
Praest P; Luteijn RD; Brak-Boer IGJ; Lanfermeijer J; Hoelen H; Ijgosse L; Costa AI; Gorham RD; Lebbink RJ; Wiertz EJHJ
Mol Immunol; 2018 Sep; 101():55-64. PubMed ID: 29879547
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.
Ahn K; Meyer TH; Uebel S; Sempé P; Djaballah H; Yang Y; Peterson PA; Früh K; Tampé R
EMBO J; 1996 Jul; 15(13):3247-55. PubMed ID: 8670825
[TBL] [Abstract][Full Text] [Related]
36. The active domain of the herpes simplex virus protein ICP47: a potent inhibitor of the transporter associated with antigen processing.
Neumann L; Kraas W; Uebel S; Jung G; Tampé R
J Mol Biol; 1997 Oct; 272(4):484-92. PubMed ID: 9325106
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of peptide and major histocompatibility complex class I/beta 2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2).
Androlewicz MJ; Ortmann B; van Endert PM; Spies T; Cresswell P
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12716-20. PubMed ID: 7809108
[TBL] [Abstract][Full Text] [Related]
38. Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP).
Koch J; Guntrum R; Heintke S; Kyritsis C; Tampé R
J Biol Chem; 2004 Mar; 279(11):10142-7. PubMed ID: 14679198
[TBL] [Abstract][Full Text] [Related]
39. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum.
Loureiro J; Lilley BN; Spooner E; Noriega V; Tortorella D; Ploegh HL
Nature; 2006 Jun; 441(7095):894-7. PubMed ID: 16738546
[TBL] [Abstract][Full Text] [Related]
40. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1.
van Hall T; Laban S; Koppers-Lalic D; Koch J; Precup C; Asmawidjaja P; Offringa R; Wiertz EJ
J Immunol; 2007 Jan; 178(2):657-62. PubMed ID: 17202325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
